The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,120.00
Bid: 12,120.00
Ask: 12,122.00
Change: 96.00 (0.80%)
Spread: 2.00 (0.017%)
Open: 11,950.00
High: 12,124.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks slip as investors digest earnings, Barclays rises

Wed, 30th Jul 2014 08:26

- Barclays rises as investors digest wave of corporate earnings- Russian sanctions, Gaza and Argentina in focus- US economic data, Fed decision due out later ontechMARK 2,785.48 +0.12%FTSE 100 6,797.66 -0.15%FTSE 250 15,671.08 -0.10%UK markets opened slightly lower on Wednesday as investors digested a wave of corporate earnings and cautiously awaited economic data and a policy decision Stateside later on.Meanwhile, traders were still watching developments in the Ukraine crisis after US and EU leaders announced a fresh round of sanctions on Russia yesterday. Relentless fighting in Gaza and a potential debt default in Argentina were also likely to be weighing on risk appetite.The FTSE 100 was trading down 0.2% at 6,798 in early trading as strong gains from Barclays, Travis Perkins and AstraZeneca were offset by falls from Antofagasta, ITV and Tullow Oil.After a relatively quiet start to the week macro-wise, things will pick up today with a flurry of economic indicators due out during the morning session, including Eurozone confidence data and Germany inflation.However, the focus is likely to be on the US later on with the closely-watched ADP employment report and second-quarter gross domestic product (GDP) estimates due out before the opening bell on Wall Street, and the Federal Reserve's policy decision scheduled for this evening.Angus Campbell, Senior Analyst at FxPro, said that the GDP figures are "like to move the market most - this is because tonight's [Fed meeting] does not include a press conference and so there's unlikely to be any changes to what we saw or heard last month".Barclays leads banks higherBarclays was a high riser this morning as it reported a less-than-expected 12% fall in total income adjusted for insurance claims for the first half to £13.32bn, driven by reductions at its investment and African banking units. The consensus estimate had been for a drop to £13.23bn.Domestic banking peers RBS and Lloyds were also on the rise.Housebuilder Travis Perkins also impressed as it reported double-digit growth across the board in the first half, with like-for-like revenues up 10.2% and profits up 16%. The company said it expects "continued solid growth" for the rest of the year.Astrazeneca was in demand after it struck a deal with drug developer Almirall for the rights to the Spanish group's respiratory franchise. The initial consideration is $875m,Chile-focused mining group Antofagasta underwhelmed as it maintained its production guidance for 2014 after a sequential increase in output in the second quarter, while net cash costs were broadly flat.Shares of broadcaster ITV were in negative territory with the stock retreating after its recent strong run. Nevertheless, the company managed to beat expectations with its first-half results this morning with pre-tax profits up 16%.Also lower was Tullow Oil as it dropped into the red in the first half of 2014, after exploration write-offs more than doubled. Tullow reported a loss before tax of $29m in the first six months of the year, compared with a profit of $486m in the first half of 2013.FTSE 100 - RisersBarclays (BARC) 226.35p +3.31%Travis Perkins (TPK) 1,679.00p +2.07%Severn Trent (SVT) 1,955.00p +0.93%AstraZeneca (AZN) 4,353.00p +0.71%Royal Bank of Scotland Group (RBS) 356.20p +0.62%Capita (CPI) 1,222.00p +0.58%Carnival (CCL) 2,139.00p +0.56%BT Group (BT.A) 389.00p +0.52%Reckitt Benckiser Group (RB.) 5,245.00p +0.48%Vodafone Group (VOD) 203.70p +0.39%FTSE 100 - FallersAntofagasta (ANTO) 838.00p -1.99%Sainsbury (J) (SBRY) 318.40p -1.52%GKN (GKN) 360.60p -1.48%CRH (CRH) 1,442.00p -1.44%Compass Group (CPG) 994.00p -1.39%WPP (WPP) 1,196.00p -0.99%Rio Tinto (RIO) 3,441.00p -0.98%TUI Travel (TT.) 364.50p -0.84%Morrison (Wm) Supermarkets (MRW) 173.10p -0.80%Sports Direct International (SPD) 687.50p -0.79%FTSE 250 - RisersPets at Home Group (PETS) 182.30p +7.24%Riverstone Energy Limited (RSE) 925.00p +2.21%IP Group (IPO) 195.90p +2.14%Dignity (DTY) 1,408.00p +1.88%Perform Group (PER) 211.00p +1.78%National Express Group (NEX) 261.00p +1.68%Diploma (DPLM) 635.50p +1.68%Fisher (James) & Sons (FSJ) 1,337.00p +1.60%Taylor Wimpey (TW.) 116.40p +1.57%BTG (BTG) 616.00p +1.48%FTSE 250 - FallersVedanta Resources (VED) 1,057.00p -3.03%Jupiter Fund Management (JUP) 406.70p -2.02%Investec (INVP) 525.50p -1.78%Pace (PIC) 355.90p -1.66%Betfair Group (BET) 1,026.00p -1.63%Beazley (BEZ) 254.30p -1.59%Rotork (ROR) 2,767.00p -1.53%Spectris (SXS) 1,931.00p -1.48%International Personal Finance (IPF) 577.50p -1.45%Fenner (FENR) 337.60p -1.43%BC
More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.